Page
%P
-
Article
Bilateral papilledema on sunitinib therapy for advanced renal cell carcinoma
We report the case of a 59-year-old man with advanced renal cell carcinoma who developed bilateral papilledema while on therapy with sunitinib, a multi-targeted tyrosine kinase inhibitor (TKI). While papillede...
-
Article
Targeted Therapies for Gastric Cancer
Gastric cancer represents one of the most common cancers internationally. Unfortunately the majority of patients still present at an advanced stage, and despite advances in diagnostic and treatment strategies,...